Results 151 to 160 of about 4,208 (171)

C3 glomerulopathy — understanding a rare complement-driven renal disease

Nature Reviews Nephrology, 2019
Richard J H Smith, Anna Blom, Mihály Józsi   +2 more
exaly  

Obesity-related glomerulopathy: An emerging epidemic

Kidney International, 2001
Julie Lin
exaly  

C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy

Kidney International, 2018
Andrew S Bomback, Pietro A Canetta, Wooin Ahn   +2 more
exaly  

C3 glomerulopathy associated with monoclonal Ig is a distinct subtype

Kidney International, 2018
Aishwarya Ravindran, Fernando C Fervenza, Richard J H Smith   +2 more
exaly  

Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy

Kidney International Reports, 2023
exaly  

Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome

Molecular Immunology, 2016
Paraskevas Iatropoulos, Marina Noris, Caterina Mele   +2 more
exaly  

C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic

Mayo Clinic Proceedings, 2018
Aishwarya Ravindran, Fernando C Fervenza, Richard J H Smith   +2 more
exaly  

De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy

Transplantation, 2012
Michelle Willicombe, Candice Roufosse
exaly  

Clinical Safety and Efficacy of Pegcetacoplan in a Phase 2 Study of Patients with C3 Glomerulopathy and Other Complement-Mediated Glomerular Diseases

Kidney International Reports, 2023
exaly  

Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy

American Journal of Kidney Diseases, 2018
Moglie Le Quintrec, Anne-Laure Sellier-Leclerc, Eric Daugas   +2 more
exaly